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AbstrAct
Objective Russia has one of the highest cardiovascular 
mortality rates. Modernisation of the Russian health 
system has been accompanied by a substantial increase in 
uptake of percutaneous coronary intervention (PCI), which 
substantially reduces the risk of mortality in patients with 
acute ST- elevation myocardial infarction (STEMI). This 
paper aims to describe contemporary Hospital treatment 
of acute STEMI among patients in a range of hospitals in 
the Russian Federation.
Methods This study used data from a prospective 
observational cohort of 1128 suspected patients with 
myocardial infarction recruited in both PCI and non- PCI 
hospitals across 13 regions and multiple levels of the 
health system in Russia. The primary objective was to 
examine the use of reperfusion strategies in patients with 
STEMI.
Results Among patients reaching PCI centres within 
12 hours of symptom onset, the vast majority received 
angiography and PCI, regardless of age, sex and 
comorbidity, in line with current European Society of 
Cardiology guidelines.
Conclusion Patients reaching Russian hospitals are 
very likely to receive appropriate treatment, although 
performance varies. The best hospitals can serve as 
beacons of good practice as PCI facilities continue to 
expand across Russia where geography allows.
IntROduCtIOn
This paper describes the management of 
patients with ST- elevation myocardial infarc-
tion (STEMI) in a selection of hospitals across 
the Russian Federation, a country that has 
received relatively little attention in the inter-
national cardiological literature, but which 
has a burden of cardiovascular disease (CVD) 
that is among the highest in the world1 and 
which has seen major investments in treat-
ment of CVD in recent years.
The management of STEMI has been 
transformed by the introduction of modern 
methods for reperfusion. Treatment must, 
however, be given rapidly, before hypoxia 
causes permanent damage to the myocar-
dium. The European Society of Cardiology 
(ESC) guidelines advocate percutaneous 
coronary intervention (PCI) by an experi-
enced team for all patients within 12 hours 
of symptom onset (early phase of STEMI).2–4 
This depends on there being a well- 
functioning, adequately resourced health 
system.5 Modernisation of the Russian health 
system has been accompanied by a substan-
tial increase in uptake of PCI in all parts of 
the country, although to a greater extent in 
some regions than in others.6 This invest-
ment is thought to have contributed, at least 
in part, to the sustained decline in mortality 
Key questions
What is already known on this subject?
 ► The management of ST- elevation myocardial in-
farction (STEMI) has been transformed by the intro-
duction of modern methods for reperfusion, notably 
percutaneous coronary intervention (PCI), use of 
which has been increasing in Russia.
 ► Little is known about individual- level patient char-
acteristics determining associated with use of PCI in 
Russia, or how PCI use varies across different levels 
of the health system with PCI facilities in Russia
What does this study add?
 ► In PCI capable centres, we demonstrate that the 
vast majority of patients are treated in line with 
European Society of Cardiology guidelines, regard-
less of patient characteristics. However, angiogra-
phy and PCI use do vary across different levels of 
the health system.
How might this impact clinical practice?
 ► There is an opportunity to reduce the variation in 
treatment of patients with STEMI in PCI- capable 
hospitals across levels of the Russian health sys-
tem. There are hospitals in Russia that can serve as 
beacons of good practice to facilitate this standard-
isation of care for patients with STEMI.
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since 2005. However, treatment intensity remains below 
that in many other countries7 and there are considerable 
challenges in providing rapid access to advanced care 
in such a vast and sparsely populated country.8 An effec-
tive response to these challenges will require an under-
standing of how the system is working.
There has been only limited research on management 
of acute myocardial infarction (AMI) in Russia so far9–11 
and relatively little is known about what happens across 
different types of medical facilities accepting AMI patients 
in Russia. This paper reports results from the first study in 
Russia designed specifically to assess contemporary treat-
ment of AMI across multiple levels of the health system 
and whether treatment varies by patient characteristics.
data and MetHOds
The protocol for the 'Management of Acute Myocardial 
Infarction in Russia’ (MAMIR) Study, part of the Inter-
national Project on Cardiovascular Disease in Russia 
(IPCDR), has been published previously.12 In brief, 
MAMIR is a prospective observational study describing 
the current treatment of AMI in Russia. A random sample 
of 1128 patients, aged 35–75 years, with a confirmed AMI 
diagnosis, and surviving 24 hours after admission to the 
hospital, within 16 hospitals across 13 regions of Russia 
from 2015 to 2017, were recruited. Hospitals were selected 
using purposive sampling, to include all types of hospital, 
large and small, and be willing to commit to organising 
data collection over the entire study period and covering 
regions of different levels of economic development from 
a large part of the territory of Russia. Of the 16 hospitals 
included, all were able to perform medical reperfusion 
therapy and 12 were able to provide PCI. For all hospi-
tals, 2015 data including number of patients with MI, 
mortality rates and PCI rates were collated from official 
statistics.13
Data for individual- level analyses came from patient 
interviews and abstracted medical records regarding 
the patients’ initial index admission. Core data include 
age, sex, STEMI status (from ECG), reperfusion treat-
ments, admission characteristics including date and time 
of admission, pre- hospital delay to hospital (<12 hours, 
12–48 hours, >48 hours), use of emergency medical 
services (EMS) and whether patients came directly to the 
hospital or via another health facility.
To capture actual practice, patients with STEMI were 
identified using an intention- to- treat approach, defined 
as having a STEMI if ST- elevation was found on their 
first ECG taken after the onset of MI symptoms (n=777). 
Appropriate treatment was determined with reference 
to the 2014 ESC guidelines, which were the guidelines 
adopted in Russia when data collection began. We have 
updated our nomenclature to match the 2017 guideline 
terms, as the 2017 revisions have no material implica-
tions for classifying treatment strategies for patients in 
our study. Specifically, we have categorised patients with 
STEMI by time from symptom onset to first medical 
contact (early phase, evolved and recent STEMI), the 
treatment indicated for each stage is described in online 
supplementary web appendix, figure 1.
PCI hospitals were divided into Federal, Regional or 
City level, corresponding broadly to decreasing levels of 
complexity of services. In PCI hospitals, age- standardised 
rates of (1) diagnostic coronary angiography (CA), first, 
initial reperfusion attempt of either (2) thrombolytic 
therapy (initial TLT) or (3) PCI (initial PCI) and (4) 
ultimate PCI use (any PCI use including initial PCI and 
rescue PCI following failed TLT) were reported, using 
the 2013 European Standard population. Differences in 
use by age, sex, pre- hospital delay and hospital level were 
tested with Pearson χ2 test and Fisher’s exact test where 
appropriate.
Further analyses were stratified by STEMI stage and 
type of hospital (PCI or non- PCI capable) to assess 
differences in AMI management by patient (age, sex 
and comorbidity) and admission characteristics (direct/
indirect routes to hospital of definitive treatment; use of 
EMS). Associations between patient and admission char-
acteristics with angiography, TLT and PCI use among 
patients with early phase STEMI (n=452), and angiog-
raphy and PCI use in patients with evolved (n=125) and 
recent (n=55) STEMI in PCI hospitals, were modelled 
using logistic regression.
Basic descriptive analyses of patients admitted to a non- 
PCI hospital, and remained 24 hours after admission, 
were undertaken by STEMI phase.
Results
Hospital characteristics
Summary characteristics of the hospitals included in 
the MAMIR Study are available in table 1. Additional 
details are available in the previously published protocol 
paper.12 13
Across PCI hospitals, use of PCI within 24 hours of 
admission varied from a low of 20.5% in Rostov to 87.8% 
of patients in Belgorod, the hospital which also had the 
lowest inpatient mortality among patients with AMI. 
Bryansk had the highest inpatient mortality; it did not 
provide PCI in 2015 but has since become a PCI hospital.
Patient characteristics
In all, 1128 patients were recruited to the MAMIR Study, 
the majority from PCI hospitals. 77.3% were men with 
mean age 57.7 years; mean age of women was 62.3. 68.9% 
of patients had a STEMI; nearly three- quarters of patients 
recruited at PCI hospitals had STEMI compared with 
40% of patients with AMI at non- PCI hospitals (table 1).
Almost 60% of all patients arrived within 12 hours 
of symptom onset, but only 40% in non- PCI hospitals; 
almost a third of patients in these hospitals arrived after 
48 hours. Two in three patients travelled directly to their 
hospital of definitive treatment, the proportion was 
greatest among those patients recruited in PCI hospitals 
(table 1). Two- thirds of patients came via EMS; a higher 
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Table 1 Characteristics of patients by PCI/non- PCI 
hospital in MAMIR Study
PCI 
centre
Non- PCI 
centre Total
χ2, p- 
value
Age (years)
  35–59 n 483 65 548 0.03, 0.872
% 48.5 49.2 48.6
  60–75 n 513 67 580
% 51.5 54.5 51.4
Sex
  Female n 224 32 256 0.20, 0.651
% 22.5 24.2 22.7
  Male n 772 100 872
% 77.5 81.3 77.3
STEMI
  No n 267 78 345 56.43, 
<0.001*% 26.8 59.1 30.6
  Yes n 723 54 777
% 72.6 40.9 68.9
  Missing n 6 0 6
% 0.6 0 0.53
Transported directly†
  No n 312 66 378 18.24, 
<0.001% 31.3 50 33.5
  Yes n 684 66 750
% 68.7 50 66.5
Transported by EMS
  No n 301 69 370 25.71, 
<0.001% 30.2 52.3 32.8
  Yes n 695 63 758
% 69.8 47.7 67.2
Pre- hospital delay‡
  <12 hours n 590 52 642 68.51, 
<0.001% 59.2 39.4 56.9
  12–48 hours n 175 25 200
% 17.6 18.9 17.7
  >48 hours n 79 41 120
% 7.9 31.1 10.6
  Missing n 152 14 166
% 15.3 10.6 14.7
Total n 996 132 1128   
% 88.3 11.7 100
*Fisher’s exact test
†Directly to hospital of definitive treatment (where patient in 
analysis sample was both finally treated for suspected AMI and 
recruited to study).
‡Delay from symptom onset to admission to hospital of 
definitive treatment.
AMI, acute myocardial infarction; EMS, emergency medical 
service; MAMIR, Management of Acute Myocardial Infarction in 
Russia 
; PCI, percutaneous coronary intervention; STEMI, ST- elevation 
myocardial infarction.
proportion of patients in PCI hospitals were transported 
by EMS.
steMI patients
Of the 777 patients with STEMI, the vast majority were 
recruited at PCI hospitals. Most patients were men and 
just over half were under 60- year old (table 2). Data on 
pre- hospital delay were available for 88% of patients; 
these complete cases had near identical proportions of 
patients by age and sex as the full sample of patients with 
STEMI. Nearly three- quarters of patients admitted to PCI 
hospitals were early phase STEMI, thus eligible for PCI 
(in the absence of contraindications); in non- PCI hospi-
tals just under half of patients arrived within 12 hours 
(table 2).
Age- standardised rates reveal that a very high propor-
tion of patients with STEMI in PCI hospitals received 
angiography; the proportion for men was slightly higher 
than women (tables 3 and 4). Among patients receiving 
CA who received subsequent PCI, this sex gap widened, 
nearly all men received PCI but only three- quarters of 
women. This gap was seen at all levels of the health system. 
Compared with Federal and Regional hospitals, PCI use 
following CA was lower among both men and women in 
City hospitals; the sex gap remained, nearly twice as many 
men received PCI following CA as women (table 3).
In the subsequent sections, we examine the extent to 
which these differences can be explained by other factors.
treatment of patients with early phase steMI
Angiography and PCI use
The vast majority of patients admitted to PCI hospitals 
within 12 hours of symptom onset received angiography 
and subsequent PCI, with no apparent differences by 
sex (table 4). Significant differences exist across the 
level of health facilities, with lower rates angiography in 
City hospitals and, inevitably, PCI, than in Federal and 
Regional hospitals. This pattern was consistent in both 
men and women (table 5). Four hospitals (two Federal 
and two Regional) performed angiography on all patients 
with early phase STEMI.
Only 31 of the 452 patients with early phase STEMI did 
not receive an angiogram (online supplementary WA, 
table 2); over a third of these patients was admitted to 
one Regional hospital, Belgorod, and were treated with 
primary TLT only. TLT use, both standalone and together 
with PCI, was particularly high among males in Regional 
hospitals, and significantly higher than women. Of the 
remaining patients that did not receive an angiogram, a 
high proportion attended one hospital, Rostov, which in 
official figures also has the lowest rate of PCI use among 
hospitals in our study (online supplementary WA, table 
1). The few patients who had CA without subsequent PCI 
either had contraindications (online supplementary WA 
table 3) or received TLT, which can be appropriate in 
certain circumstances (such as stenosis of <50%). These 
patients were evenly distributed among hospitals. Thus, 
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the low use of PCI in Rostov seems due to reduced access 
to angiography.
Looking at the combined effects of patient and admis-
sion characteristics on CA and subsequent PCI using 
logistic regression (table 6), there was no significant 
association between sex and having an angiogram or, 
subsequently, undergoing PCI. Age was not associated 
with pathway to hospital. There was, however, a much 
lower probability of receiving an angiogram if admitted 
to a City hospital compared with a Federal hospital, but 
among those who did have one, the odds of going on to a 
PCI, while lower, were not significantly so. A formal test of 
interaction found no evidence that the association of sex 
with having an angiogram varied by hospital level. Impor-
tantly, there was no reduction in the odds of receiving 
PCI among those admitted outside working hours. For 
all variables, however, the confidence intervals were wide.
Route to hospital and treatment en route
The first medical contact of nearly all patients with early 
phase STEMI was EMS (online supplementary WA table 
4). 88.8% of patients transported by EMS was given 
aspirin prior to arrival at hospital, while a further 4.6% 
had already taken it. Almost all the remainder were given 
it after arrival at hospital. The corresponding figures 
for patients with evolved STEMI were 91.3% and 4.4%. 
Among patients at PCI hospitals, a third received TLT, 
with the majority receiving TLT prior to arrival (online 
supplementary WA table 4). Pre- hospital TLT use was 
significantly higher among patients travelling indirectly 
to the PCI hospital (via non- PCI facility), more than 
double the proportion of patients travelling directly by 
ambulance (online supplementary WA table 4). Almost 
half of patients transported by EMS for over 60 km 
received TLT in the ambulance, significantly more than 
the 18% of patients transported across shorter distances 
(online supplementary WA table 5).
treatment of evolved steMI in PCI hospitals
20% of patients with STEMI at PCI hospitals presented 
with evolved STEMI, the vast majority underwent angi-
ography (tables 2 and 4). There was no sex difference 
and while all those without comorbidity underwent this 
procedure, the corresponding figure was slightly, though 
significantly, lower for those with comorbidity (93%, 
n=45) (table 7). Among patients having subsequent PCI, 
however, a sex difference was found; PCI was received 
by nearly all men having CA but only 81% of women 
(table 4). After adjusting for age and comorbidity, this 
difference remained; the OR for receiving a PCI among 
men relative to women was 5.25 (95% CI: 1.14 to 24.13) 
(online supplementary WA table 6).
Route to hospital and TLT use
The majority of patients transferred from non- PCI hospi-
tals arrived at the PCI hospital within 24 hours (67%), of 
those that did not are unable to assess if this is due to later 
arrival at the non- PCI hospital or prolonged door- to- door 
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Table 6 ORs for having angiogram and ultimate PCI among patients with early stage STEMI in PCI hospitals
ALL early phase STEMI patients
Early phase STEMI patients that 
had angiogram
OR of having angiogram /no angiogram
(95% CI)
OR of having ultimate PCI/*no PCI
(95% CI)
Male (ref: female) 1.15 (0.46 to 2.88) 1.44 (0.61 to 3.42)
Age 60–75 (ref: 35–59) 0.62 (0.27 to 1.43) 0.73 (0.33 to 1.59)
Direct route (ref: indirect) 0.38 (0.08 to 1.71) 0.50 (0.17 to 1.48)
Regional Level Hospital (ref: Federal) 0.16 (0.02 to 1.24) 0.88 (0.36 to 2.14)
City Level Hospital (ref: Federal) 0.02***(0.00 to 0.19) 0.46 (0.15 to 1.37)
Comorbid (ref: no) 0.79 (0.35 to 1.78) 0.92 (0.42 to 2.02)
Admitted 00:00-05:59 (ref: 06:00-17:59) 1.03 (0.26 to 4.08) 2.65 (0.59 to 11.91)
Admitted 18:00-23:59 (ref: 06:00-17:59) 0.61 (0.26 to 1.43) 1.34 (0.57 to 3.18)
Constant 445.29*** (32.81 to 6043.91) 21.06*** (4.48 to 98.85)
N 452 420†
*p<0.05, **p<0.01, ***p<0.001.
†One further case excluded due to missing data.
PCI, percutaneous coronary intervention; STEMI, ST- elevation myocardial infarction.
transfer from non- PCI hospital to PCI hospital. The 
majority of patients with evolved STEMI travelling by 
ambulance did not receive TLT, in line with ESC guide-
lines.
treatment of recent steMI in PCI hospitals
Approximately 1 in 11 patients with STEMI presented 
very late at PCI hospitals (table 2). 90% of patients with 
recent STEMI had CA. There were no significant differ-
ences in the odds of having angiography by sex, age or 
comorbidity, although the values of n were small. No 
patients with recent STEMI with comorbidities went on 
to have a PCI; there were no differences in the odds of 
having PCIs by age and sex (online supplementary WA 
tables 7 and 8).
treatment at non-PCI hospitals
40% of patients with MI at non- PCI hospitals had STEMI, 
a significantly lower proportion than in PCI hospitals 
(70% patients with MI were STEMI) suggesting that, in 
general, early phase STEMI are being transferred on to 
PCI hospitals after admission, but clearly not all (table 1). 
Among the 54 patients with STEMI in non- PCI hospitals, 
data on pre- hospital delay were available for 49 (table 2). 
Just under half of these patients presented with an early 
phase STEMI yet were not transferred to PCI hospitals. 
In addition, eight patients had been transferred into the 
non- PCI hospital from another non- PCI hospital. We were 
unable to determine reasons why these patients were not 
transferred to a PCI hospital. Data on treatment for early 
phase STEMI at non- PCI hospitals were available for 22 of 
23 patients, half of whom received TLT. Treatment varied 
across the hospitals with all, or almost all patients in three 
of the four hospitals receiving no TLT, but 10 of 12 in a 
fourth received TLT (online supplementary WA table 9).
dIsCussIOn
The main, and the most important, finding is that, among 
those patients reaching PCI hospitals included in this 
study and surviving 24 hours, the vast majority were inves-
tigated and treated in line with current ESC guidelines. 
Previously, we have documented the dramatic expansion 
in health facilities equipped for PCI across Russia.7 Our 
findings suggest that across a range of these mainly new 
PCI hospitals the needs of patients with STEMI that reach 
them on time, are largely met.
Notwithstanding the need for caution given the purpo-
sive nature of the study design, within those meeting our 
inclusion criteria, the majority of patients with STEMI in 
Russia present in the early phase and those who reach 
PCI hospitals at this stage and have angiography have a 
very high probability of PCI. Indeed, while a number of 
studies in countries other than Russia have found that 
compared with men, women with CVD receive suboptimal 
treatment and have higher risks of adverse outcomes, our 
study finds, among patients with early phase STEMI who 
can be expected to benefit most, no significant differ-
ence in PCI use by sex after adjusting for comorbidity, 
age and hospital type. This is in line with more recent 
research suggesting that the well- known sex disparities 
could be explained by differences in case mix.14 15 More-
over, consistent with ESC guidelines, patients who did not 
receive PCI after angiography tended to have multivessel 
disease or other contraindications, while PCI use did 
not vary according to the admission route taken by the 
patient or time of admission, suggesting that hospitals 
really do offer a 24- hour service. We did, however, find 
a sex difference in PCI use among patients with evolved 
STEMI.
Adherence to ESC recommendations did vary; we 
identified differences in angiography and PCI use across 
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different levels of hospital. Although angiography rates 
are high overall in patients with STEMI, they are signifi-
cantly lower in City hospitals in our sample. Moreover, 
patients with STEMI in City hospitals who have an angio-
gram are less likely to have PCI (table 3). Additionally, 
we identified one hospital, Rostov, as an outlier in our 
sample: nearly half of all patients with early phase STEMI 
do not receive an angiogram there. While official figures 
indicate that a very low proportion of patients arrive 
there within 24 hours, the MAMIR data highlight that 
even among patients who do arrive early, angiogram use 
is low. Pre- hospital delay alone does not explain the low 
use of angiography, and thus subsequent PCI, in these 
patients with STEMI. Further investigation revealed that 
even though this hospital does provide PCI, it is not the 
main hospital for PCI in the region. Thus, while it seems 
most patients with AMI are taken to another hospital if 
time and distance permits, improvements in treatment 
for those patients left behind are possible.
A key finding from the study is that a number of hospi-
tals in our study performed particularly well in specific 
areas of AMI management that were in line with ESC 
guidelines. Indeed, four hospitals offered angiography 
to all patients with early phase STEMI. These hospitals 
could potentially serve as a beacon to others, offering 
scope for shared learning. Additionally, AMI manage-
ment of patients with early phase STEMI is particularly 
good, while there remains room for improvement for 
evolved and recent STEMI, in particular, with sex differ-
ences in PCI use existing among patients with evolved 
STEMI. Inter- hospital knowledge transfer will be particu-
larly important as PCI health facilities continue to expand 
across the Russian Federation, in addition to strategies to 
improve pre- hospital delays.
The challenge now is to ensure that those facilities 
that are lagging behind are brought up to the standards 
observed in the best. Since 2010, the Federal Ministry 
of Health has adopted a range of measures designed to 
improve quality of care. These include both additional 
resources for healthcare and various targeted new initia-
tives such as revised clinical practice guidelines, drawing 
on international standards, pay for performance schemes, 
electronic medical records and various quality control 
programmes. These have been described in a recent 
review, which documented a high level of commitment 
to better quality care but also very limited evaluations, 
reflecting the lack of capacity for health services research 
in Russia.16 However, a further challenge is the persisting 
siloed and hierarchical management structure in many 
Russian hospitals, something that is deeply embedded in 
the system and will be difficult to overcome.17
 
This study also provides some evidence on pathways 
tohospital and TLT use for patients with STEMI in 
these hospitals. Just over a quarter of patients arrived at 
hospital 12 hours after symptom onset. Pre- hospital delay 
is a complicated issue, which involves both health seeking 
behaviour (patient delays) and health system factors 
(transportdelays). Patient delays (prolonged delays from-
symptom onset to seeking help) can reflect many factors, 
from symptom recognition to proximity and access 
to care. A proper understanding will require detailed 
research on health seeking behaviour using qualitative 
and quantitative approaches.
A key finding of this study is that there is a largepro-
portion of patients with STEMIwhohave long travel times 
to PCI hospitalsbut do not receive TLT. The STREAM 
trial examined the effectiveness of TLT inthose unable 
to receive immediate PCI. Subjects were randomised to 
either delayed (median 3 hours) PCI or rapid admin-
istration of TLT with rapid PCI where that failed or 
otherwise at 6-24 hours. Those receiving TLT achieved 
as good cardiac outcomes as those undergoing primary 
PCI, although they experienced a slightly high rate of 
bleeding.18 Thus, in Russia, when patients are unable 
to obtain immediate PCIs butcan be transferred to a 
hospital where it is available, the administration of TLT 
is a tractable measure that could improve prognosis for 
patients with AMI.
In a separate study, we have mapped road travel times 
from all Russian districts to the nearest facility providing 
PCI in 2015 (both in the same region and in neigh-
bouring ones).8 This identified two strategies that could 
reduce travel times and thus, hopefully, delays. The first 
was the creation of 67 new PCI centres, in addition to 
the 260 that were then operating. This would increase 
the share of the population within 60 min travel time by 
almost nine percentage points, benefiting 5.7 million 
people. The second was to permit people living near 
regional borders to attend the closest facility, wherever it 
was. However, this would increase the number of people 
within 60 min travel time by only 340 000.
Ultimately, in Russia as elsewhere, there is likely to 
be scope for integrated planning of services, spanning 
the entire patient journey. This has proven successful 
with the acute management of stroke, as in London 
and, in varying forms, some other places, and a similar 
approach is being evaluated in seven tertiary hospitals in 
Germany.19–22 However, the organisational challenges are 
considerable as this model has been difficult to imple-
ment elsewhere.
The results we have presented should be interpreted 
with caution as the MAMIR Study has several important 
limitations. These, to some extent, reflect the challenge 
of conducting health services research outside major 
hospitals. Our sample is intentionally diverse, covering 
multiple levels of the health system to describe contem-
porary management of patients with AMI in Russia. The 
hospitals included cannot, however, be taken as repre-
sentative of the overall situation in Russia, as we were 
constrained in selecting only those where it was possible 
to gain commitment by a local co- investigator. Within this 
constraint, we did sample purposively to cover the geog-
raphy of Russia and facilities at all levels within the health 
system. However, as we have shown previously, there is 
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considerable variation in the extent to which regions 
have adopted advanced management of AMI7 and, taking 
the PCI rate per 100 000 in 2013 as an indicator of prog-
ress, we also span the entire range of those providing a 
service at that time. Thus, we included two regions in the 
top quintile of activity, and 4, 2, 3 and 2 in each quintile 
of declining activity.
Despite strenuous efforts, there was a relatively high 
level of missing data, including lack of information on 
pre- hospital delays in 96 patients with STEMI and we were 
unable to obtain detailed data that would have allowed 
us to understand overall patient flows within the hospital 
system and, specifically, how many patients arrived at a 
non- PCI hospital and were transferred. Nonetheless, the 
data from this study provide a much improved evidence 
base from which to assess the current management of 
patients with AMI in the Russian Federation.
COnClusIOns
Our data provide a valuable snapshot of the management 
of AMI in the Russian health system. Our findings offer 
some grounds for reassurance as, once patients reach 
hospitals offering PCI, they do seem to receive treat-
ment consistent with ESC recommendations. However, 
there are also areas that could be improved. First, there 
is greater scope to ensure consistent, standardised care 
is received by patients across health facilities (both 
within PCI and non- PCI hospitals), and, in particular, 
increasing access to angiography and subsequent PCI. 
Additionally, there is scope to increase use of pre- hospital 
TLT in those who could benefit in many of the regions 
included, particularly in patients transferred indirectly 
or over greater distances. However, a key finding of the 
study is that there are multiple hospitals in Russia that are 
providing high- quality care to patients with AMI. These 
hospitals can serve as beacons of good practice as PCI 
facilities continue to expand across Russia.
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